8-K: Lifecore Biomedical Appoints KPMG as New Auditor

Lifecore Biomedical, Inc. has appointed KPMG LLP as its new independent registered public accounting firm, replacing BDO USA, P.C., effective August 12, 2025.

Summary

• Lifecore Biomedical, Inc. (LFCR) has appointed KPMG LLP as its new independent registered public accounting firm for the transition period beginning May 26, 2025, and ending December 31, 2025.
• The Audit Committee of the Board of Directors approved the appointment of KPMG and the dismissal of the previous firm, BDO USA, P.C., on August 12, 2025.
• BDO's audit reports on the company's consolidated financial statements for the fiscal years ended May 26, 2024, and May 25, 2025, did not contain adverse or disclaimer opinions, nor were they qualified or modified.
• However, BDO's reports on the effectiveness of internal control over financial reporting for May 26, 2024, and May 25, 2025, stated that the company did not maintain effective internal control due to material weaknesses.
• No disagreements or reportable events occurred between the company and BDO, other than the previously disclosed material weaknesses in internal control over financial reporting.
• The company did not consult with KPMG on accounting principles, audit opinions, disagreements, or reportable events prior to their engagement.

Sentiment

Score: 4

Explanation: The change in auditors is a neutral event, but the persistent material weaknesses in internal controls over financial reporting are a significant concern, indicating ongoing issues with financial reporting processes. While the company is taking steps to address this by appointing a new auditor, the underlying issues remain.

Positives

• The Audit Committee has concluded its process to select a new independent registered public accounting firm, ensuring continuity in audit oversight.
• The company's financial statements for the past two fiscal years did not receive adverse or qualified opinions from the former auditor, BDO.

Negatives

• The company did not maintain effective internal control over financial reporting for the fiscal years ended May 26, 2024, and May 25, 2025, due to identified material weaknesses.
• Material weaknesses persisted as of May 25, 2025, specifically relating to Information and Communication, Control Activities, and Monitoring components of the COSO framework.

Risks

• Material weaknesses in internal control over financial reporting, which could impact the reliability of financial statements.
• Deficiencies in the Control Environment, including insufficient personnel to support internal control objectives.
• Inadequate Risk Assessment, particularly regarding the identification and assessment of risks from business model changes and disposition activities.
• Weaknesses in Information and Communication, affecting the completeness and accuracy of information used in control activities.
• Ineffective Monitoring activities, leading to delays in identifying and remediating control deficiencies.
• Ineffective Control Activities resulting from the broader weaknesses in other COSO components.
• Specific issues related to material weaknesses include accounting for non-standard transactions, inventory valuation, capitalization of interest, development revenue recognition, operating cost presentation, and write-off of receivables from former Curation Foods businesses.

Future Outlook

No specific forward-looking statements or financial guidance were provided in this filing beyond the engagement period for the new auditor.

Management Comments

• The Audit Committee discussed the weaknesses in the company's internal control over financial reporting with BDO and authorized BDO to respond fully to inquiries of KPMG concerning such material weaknesses.

Industry Context

The change of independent registered public accounting firms is a common corporate governance practice, often occurring periodically as companies review their audit relationships. However, the context of persistent material weaknesses in internal controls highlights a challenge that many companies face, particularly those undergoing significant operational changes or business model adjustments, such as disposition activities.

Corporate Governance

Stakeholder Impact

• Shareholders: May face concerns regarding the reliability of financial reporting due to persistent material weaknesses in internal controls, potentially impacting investor confidence.
• Management: Will be responsible for working with the new auditor and continuing efforts to remediate the identified internal control deficiencies.
• Employees: Those involved in financial reporting and control functions may experience increased workload and scrutiny as remediation efforts continue.

Next Steps

• KPMG LLP will serve as the independent registered public accounting firm for the company's transition period ending December 31, 2025.
• The company is expected to continue its efforts to remediate the identified material weaknesses in internal control over financial reporting.

Key Dates

Recommendation

The change in auditors is a standard corporate action. However, the persistent material weaknesses in internal controls over financial reporting, as highlighted by the former auditor, are a significant concern. While the company is addressing these, the ongoing nature of these issues suggests a 'hold' position until there is clear evidence of remediation and improved financial reporting reliability. The appointment of a new Big Four firm like KPMG might be seen as a positive step towards strengthening controls, but the underlying issues remain.

Keywords

Lifecore Biomedical, LFCR, SEC filing, 8-K, auditor change, KPMG, BDO, internal controls, material weaknesses, financial reporting, corporate governance, accounting firm